-
11301por Chin, Stacey E., Schindler, Christina, Vinall, Lisa, Dodd, Roger B., Bamber, Lisa, Legg, Sandrine, Sigurdardottir, Anna, Rees, D. Gareth, Malcolm, Tim I. M., Spratley, Samantha J., Granéli, Cecilia, Sumner, Jonathan, Tigue, Natalie J.“…Here we describe a CID module based on the orally available, approved, small molecule simeprevir and its target, the NS3/4A protease from hepatitis C virus. We demonstrate the utility of this CID module as a molecular switch to control biological processes such as gene expression and apoptosis in vitro, and show that the CID system can be used to rapidly induce apoptosis in tumor cells in a xenograft mouse model, leading to complete tumor regression.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11302por Lima, Claudianne Maia de Farias, Rebouças, Tatyane Oliveira, Carlos, Luciana Maria de Barros, Oliveira, Juliana Bezerra Frota, da Silva, Eulene Lima, Alves, Janaína Soares, de Lima, Clébia Azevedo, Mesquita, Felipe Pantoja, Ribeiro, Jannison Karly Cavalcante, de Aquino, Pedro Everson Alexandre, Brunetta, Denise Menezes, Garcia, José Huygens Parente, Viana, Antonio Brazil“…The leading causes of liver disease were hepatitis C (113 cases, 34.6%) and alcohol-related liver disease (97 cases, 29.7%). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11303A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomespor Schultz, Anne-Kathrin, Zhang, Ming, Leitner, Thomas, Kuiken, Carla, Korber, Bette, Morgenstern, Burkhard, Stanke, Mario“…We applied our method to a large set of genome sequences from human immunodeficiency virus (HIV) and hepatitis C virus (HCV) as well as to simulated recombined genome sequences. …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11304“…BACKGROUND: Percutaneous exposure incidents facilitate transmission of bloodborne pathogens such as human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11305por Sallie, Richard“…Interferon (IFN) and ribavirin, are effective drugs used to treat hepatitis C (HCV), but the mechanism(s) of their action are uncertain. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11306por Spee, Bart, Arends, Brigitte, van den Ingh, Ted SGAM, Roskams, Tania, Rothuizen, Jan, Penning, Louis C“…Canine cirrhotic samples were compared to human liver samples from cirrhotic stages of alcoholic liver disease (hALC) and chronic hepatitis C infection (hHC). RESULTS: Canine specific mRNA expression of the regenerative hepatocyte growth factor (HGF) signaling pathway and relevant down-stream pathways were measured by semi-quantitative PCR and Western blot (STAT3, PKB, ERK1/2, and p38-MAPK). …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11307por Kohjima, Motoyuki, Enjoji, Munechika, Higuchi, Nobito, Kotoh, Kazuhiro, Kato, Masaki, Takayanagi, Ryoiichi, Nakamuta, Makoto“…BACKGROUND/AIMS: A recent decrease in patient survival has been reported among hepatitis C virus (HCV)-infected liver transplant recipients and this may be attributable to progression of fibrosis. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11308por Kaushik-Basu, Neerja, Bopda-Waffo, Alain, Talele, Tanaji T., Basu, Amartya, Costa, Paulo R. R., da Silva, Alcides J. M., Sarafianos, Stefan G., Noël, François“…The hepatitis C virus (HCV) NS5B is essential for viral RNA replication and is therefore a prime target for development of HCV replication inhibitors. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11309por Takayama, Hidehito, Chelikani, Prashen, Reeves, Philip J., Zhang, Shuguang, Khorana, H. Gobind“…It has recently been identified as the putative receptor for the Hepatitis C Virus envelope E2 glycoprotein (HCV-E2). …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11310por Ancuta, Petronela, Kamat, Anupa, Kunstman, Kevin J., Kim, Eun-Young, Autissier, Patrick, Wurcel, Alysse, Zaman, Tauheed, Stone, David, Mefford, Megan, Morgello, Susan, Singer, Elyse J., Wolinsky, Steven M., Gabuzda, Dana“…LPS levels were higher in AIDS patients using intravenous heroin and/or ethanol, or with Hepatitis C virus (HCV) co-infection, compared to control groups. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11311“…Compared with excluding notifications with unknown Aboriginality data from the analysis, or apportioning notifications with unknown Aboriginality based on the proportion of cases with known Aboriginality, the rate ratios of chlamydia, syphilis and hepatitis C among Aboriginal relative to non-Aboriginal people decreased when Aboriginality data from data linkage was included. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11312por Cooper, Curtis L, Ahluwalia, Navneet K, Efler, Susan M, Vollmer, Jörg, Krieg, Arthur M, Davis, Heather L“…BACKGROUND: Chronic hepatitis C virus (HCV) infection results from weak or absent T cell responses. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11313por Spoden, Gilles, Freitag, Kirsten, Husmann, Matthias, Boller, Klaus, Sapp, Martin, Lambert, Carsten, Florin, Luise“…CONCLUSIONS/SIGNIFICANCE: Tetraspanins fulfill various roles in the life cycle of a number of important viral pathogens, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV). However, their involvement in endocytosis of viral particles has not been proven. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11314por Vali, Bahareh, Yue, Feng Yun, Jones, R. Brad, Sheth, Prameet M., Kaul, Rupert, Betts, Michael R., Wong, David, Kovacs, Colin, Loutfy, Mona, Common, Andrew, Halpenny, Roberta, Ostrowski, Mario A.“…BACKGROUND AND AIMS: Hepatitis C Virus (HCV)-related liver disease progresses more rapidly in individuals co-infected with Human Immunodeficiency Virus-1 (HIV), although the underlying immunologic mechanisms are unknown. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11315“…The groups of patients with cirrhosis due to alcohol, hepatitis C, or cholestatic liver disease did not differ in severity of liver cirrhosis or the prevalence of hepatic encephalopathy (p > 0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11316por Khan, Saeed, Rai, Mohammad A, Khan, Adnan, Farooqui, Amber, Kazmi, Shahana U, Ali, Syed H“…OBJECTIVE: The objective of the study reported here was to determine the prevalence of Human Immunodeficiency and Hepatitis C viruses (respectively, HIV and HCV) in the earthquake-affected communities of Pakistan. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11317“…The safety of the blood supply, an issue in the 1970s and 1980s, created an increased need to screen the blood supply for HIV-1 and hepatitis C virus infections. The possibility exists that other contamination could again affect the blood supply. …”
Enlace del recurso
Enlace del recurso
Texto -
11318por Vucinovic, Mirjana, Roje, Damir, Vučnović, Zoran, Capkun, Vesna, Bucat, Marija, Banović, Ivo“…Premature delivery was significantly more common in the group of pregnant addicts (21% vs. 6%); 49% of pregnant addicts were carriers of hepatitis C virus (HCV) and 14% of hepatitis B virus (HBV). …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11319por Baumbach, Joan P, Foster, Lily N, Mueller, Mark, Cruz, Michelle Firestone, Arbona, Sonia, Melville, Sharon, Ramos, Rebeca, Strathdee, Steffanie A“…In Mexico, Texas and New Mexico, respectively: hepatitis B virus (HBV) was seen in 88.3%, 48.6% and 59.6% of participants; hepatitis C virus (HCV) in 98.7%, 76.4% and 80.0%; human immunodeficiency virus (HIV) in 2.1%, 10.0% and 1.0%; and syphilis in 4.0%, 9.9% and 3.0%. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11320“…Of the 12 countries included in the study, nine screened all donors for HIV; three screened all donors for hepatitis B virus (HBV); two screened all donors for Trypanosoma cruzi; none screened all donors for hepatitis C virus (HCV); and six screened some donors for syphilis. …”
Enlace del recurso
Enlace del recurso
Texto